Nanomedicine: novel approaches in human and veterinary therapeutics (Q37890639)

24 August 2017

1 reference

title

Nanomedicine: novel approaches in human and veterinary therapeutics (English)

1 reference

24 August 2017

1 reference

Juan M Irache

1

1 reference

24 August 2017

Irene Esparza

2

1 reference

24 August 2017

Carlos Gamazo

3

1 reference

24 August 2017

Maite Agüeros

4

1 reference

24 August 2017

Socorro Espuelas

5

1 reference

24 August 2017

27 May 2011

1 reference

24 August 2017

Veterinary Parasitology

1 reference

24 August 2017

180

1 reference

24 August 2017

47-71

1 reference

24 August 2017

1-2

1 reference

Novel drug release profiles from micellar solutions of PLA-PEO-PLA triblock copolymers

24 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Combined hydroxypropyl-beta-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Liposomes as immunological adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Body distribution of polysorbate-80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Influence of the surfactant concentration on the body distribution of nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Gantrez AN as a new polymer for the preparation of ligand-nanoparticle conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Albumin nanoparticles as carriers for a phosphodiester oligonucleotide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Bovine serum albumin modified the intracellular distribution and improved the antiviral activity of an oligonucleotide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Diffusion of univalent ions across the lamellae of swollen phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Colloidal drug carriers: achievements and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymeric nano- and microparticle technologies for oral gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymerized micelles and their use as adjuvants in immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Chitosan nanoparticles for oral drug and gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Lipid nanoparticles for the delivery of poorly water-soluble drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Bacterial invasion: a new strategy to dominate cytoskeleton plasticity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanocapsule technology: a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanotechnologies for drug delivery: Application to cancer and autoimmune diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanotechnology: intelligent design to treat complex disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Sub-compartmentalization of the gastrointestinal (GI) immune system determined with microbeads that differ in release properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymeric micelles for drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

The performance of nanocarriers for transmucosal drug delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Dendrimer-drug interactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Design and influence of gamma-irradiation on the biopharmaceutical properties of nanoparticles containing an antigenic complex from Brucella ovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Evaluation of particulate acellular vaccines against Brucella ovis infection in rams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Efficient Salmonella entry requires activity cycles of host ADF and cofilin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Beta-1,2- and alpha-1,2-linked oligomannosides mediate adherence of Candida albicans blastospores to human enterocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Purification of PEGylated nanoparticles using tangential flow filtration (TFF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

7 January 2021

Drug delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Targeting of 3'-azido 3'-deoxythymidine (AZT)-loaded poly(isohexylcyanoacrylate) nanospheres to the gastrointestinal mucosa and associated lymphoid tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Gastrointestinal uptake of biodegradable microparticles: effect of particle size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymer conjugates as anticancer nanomedicines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Incorporation of macromolecules in microparticles: preparation and characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

In vitro antileishmanial activity of amphotericin B loaded in poly(epsilon-caprolactone) nanospheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Treatment of experimental salmonellosis in mice with ampicillin-bound nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Solubilization and Release Properties of Dendrimers. Evaluation as Prospective Drug Delivery Systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Inhibition of malarial topoisomerase II in Plasmodium falciparum by antisense nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymeric micelles for oral drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Development of a novel vaccine delivery system based on Gantrez nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Allergen immunotherapy with nanoparticles containing lipopolysaccharide from Brucella ovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Biodegradable long-circulating polymeric nanospheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Lysosomal localization of -fructofuranosidase-containing liposomes injected into rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Protein-polymer conjugates: synthetic approaches by controlled radical polymerizations and interesting applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymer therapeutics: concepts and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Effect of pegylation on pharmaceuticals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Protein nanoparticles as drug carriers in clinical medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Synthesis of protein-polymer conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

A novel phase inversion-based process for the preparation of lipid nanocarriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

The influence of lipid nanocapsule composition on their size distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymer-based nanoparticles for the delivery of nucleoside analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Liposomes in ultrasonic drug and gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Lipid nanocapsules: a new platform for nanomedicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Factors affecting toxicity and efficacy of polymeric nanomedicines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Chitosan as a novel nasal delivery system for vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Preparation and characterization of lectin-latex conjugates for specific bioadhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Albumin nanoparticles for the intravitreal delivery of anticytomegaloviral drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Mannose-targeted systems for the delivery of therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Poly(anhydride) nanoparticles as adjuvants for mucosal vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Interaction of modified cyclodextrins with cytochrome P-450.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Anti-microbial activities of mannose-binding lectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Lipid nanoparticles for parenteral delivery of actives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Block copolymer micelles for drug delivery: design, characterization and biological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Mannan-binding lectin: clinical significance and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Epithelial M cells: differentiation and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanoparticles--a historical perspective.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Biodegradable polymeric nanoparticles based drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymeric micelles for delivery of poorly water-soluble compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Arterial uptake of biodegradable nanoparticles: effect of surface modifications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Novel applications of liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Intracellular killing of Brucella melitensis in human macrophages with microsphere-encapsulated gentamicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymer-drug conjugates: recent development in clinical oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Current advances in research and clinical applications of PLGA-based nanotechnology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Protein-based nanomedicine platforms for drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Chitosan micro- and nanospheres: fabrication and applications for drug and DNA delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Solid lipid nanoparticles: production, characterization and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanosizing: a formulation approach for poorly-water-soluble compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Drug nanoparticles: formulating poorly water-soluble compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Ganciclovir-loaded albumin nanoparticles: characterization and in vitro release properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Efficacy of ganciclovir-loaded nanoparticles in human cytomegalovirus (HCMV)-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Biomedical applications of dendrimers: a tutorial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Poloxamers and poloxamines in nanoparticle engineering and experimental medicine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanomedicine: current status and future prospects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Functional polymers for targeted delivery of nucleic acid drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Aberrant vascular architecture in tumors and its importance in drug-based therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polyester microparticles as a vaccine delivery system for brucellosis: influence of the polymer on release, phagocytosis and toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Chitosan nanoparticles: a promising system in novel drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Preparation, characterization and evaluation of targeting potential of amphotericin B-loaded engineered PLGA nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Approaches to development of microencapsulated form of the live measles vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Development of oral microencapsulated forms for delivering viral vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Humoral immune response in hens naturally infected with Salmonella Enteritidis against outer membrane proteins and other surface structural antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Non-adhesive cyanoacrylate as an embolic material for endovascular neurosurgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Drug targeting by polyalkylcyanoacrylate nanoparticles is not efficient against persistent Salmonella.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Drug delivery using multifunctional dendrimers and hyperbranched polymers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Antitubercular inhaled therapy: opportunities, progress and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Drug targeting to the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Biodegradable polymers for microencapsulation of drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymeric nanoparticles for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Metronomic chemotherapy: new rationale for new directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in Asian sea bass (Lates calcarifer) to protect from Vibrio (Listonella) anguillarum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Oral delivery of DNA construct using chitosan nanoparticles to protect the shrimp from white spot syndrome virus (WSSV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Effective nasal influenza vaccine delivery using chitosan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Clinical Implications of N-(2-Hydroxypropyl)Methacrylamide Copolymers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Toward ‘smart’ nano-objects by self-assembly of block copolymers in solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

The present and future of nanotechnology in human health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Adsorption of amphipathic dendrons on polystyrene nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Salmonella-like bioadhesive nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Evaluation of bioadhesive capacity and immunoadjuvant properties of vitamin B(12)-Gantrez nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Immunoadjuvant capacity of flagellin and mannosamine-coated poly(anhydride) nanoparticles in oral vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanotechnology applied to the treatment of malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Modulation of oral bioavailability of anticancer drugs: from mouse to man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Gamma interferon loaded onto albumin nanoparticles: in vitro and in vivo activities against Brucella abortus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Past, present, and future technologies for oral delivery of therapeutic proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Biodegradable polymeric nanoparticles as drug delivery devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Design of folic acid-conjugated nanoparticles for drug targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Immunity in response to particulate antigen-delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Solubilizing excipients in oral and injectable formulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Cationic polymer optimization for efficient gene delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Poly(anhydride) nanoparticles act as active Th1 adjuvants through Toll-like receptor exploitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Clinical pharmacology of anticancer agents in relation to formulations and administration routes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Stealth PLA-PEG nanoparticles as protein carriers for nasal administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Recent advances with liposomes as pharmaceutical carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Micellar nanocarriers: pharmaceutical perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanomicellar formulations for sustained drug delivery: strategies and underlying principles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Gene delivery by lipoplexes and polyplexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Influence of the surface properties of low contact angle surfactants on the body distribution of14C-poly(methyl methacrylate) nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

L-MBP is expressed in epithelial cells of mouse small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Poly(ethylene glycol)-b-poly(epsilon-caprolactone) and PEG-phospholipid form stable mixed micelles in aqueous media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Methods for the preparation and manufacture of polymeric nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Polymer conjugates: nanosized medicines for treating cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Design of biodegradable particles for protein delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

PEG-PLA nanoparticles as carriers for nasal vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

The Phenomenon of Persorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Nanomedicine: what's in a definition?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Pain and the blood-brain barrier: obstacles to drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Intranasal vaccination with chitosan-DNA nanoparticles expressing pneumococcal surface antigen a protects mice against nasopharyngeal colonization by Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Dendrimers as drug carriers: applications in different routes of drug administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Bioadhesive properties of pegylated nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Formation of novel polymeric nanoparticles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

Recent advances in protein and peptide drug delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2011.05.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETPAR.2011.05.028

1 reference

24 August 2017

1 reference